Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Calgary

$27,000.00

Clinical and Quality of Life Outcomes of Biliary Endoprosthesis in Patients Presenting with Malignant Biliary Obstruction

FY 2025-26

Summary
Malignant biliary obstruction (MBO) is a clinically significant medical condition where the common bile duct (CBD) becomes blocked due to cancer. There are many causes of MBO including cancer of the pancreas, bile duct, and liver. Treatment involves performing an endoscopic retrograde cholangiopancreatography (ERCP) with insertion of a plastic or metal stent in the CBD to relieve the obstruction. Biliary stenting can potentially improve symptom-free survival and be beneficial in certain subgroup of patients. However, further research is needed to understand which patient population benefit from ERCP intervention considering its adverse events. The proposed project will include both a retrospective and prospective analysis of patients diagnosed with MBO undergoing biliary stenting. In the retrospective portion, we will assess various clinical outcomes including technical and procedural success, patient mortality, unplanned hospital visits, and procedural adverse events. In the prospective cohort of patients, we will assess the same clinical outcomes along with various patient reported outcomes and patient-centered outcomes. This includes quality of life measures, time to chemotherapy, healthcare contact and hospital free days. This project will be conducted at the Peter Lougheed Center by utilizing a well-maintained registry of patients undergoing ERCP procedures in Calgary since 2018. Results from this project will aim to provide real-world data on which subset of patients benefit from ERCP for the treatment of MBO. Establishing an evidence-based approach in this patient population will help improve clinical outcomes, reduce iatrogenic complications, and potentially lead to improvement in quality of life.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572800
Name
Malik Getanshu
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Clinical and Quality of Life Outcomes of Biliary Endoprosthesis in Patients Presenting with Malignant Biliary Obstruction
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Biliary Endoprosthesis; Biliary Stenting; Endoscopic Retrograde Cholangiopancreatography (Ercp); Gastroenterology; Hepatobiliary Cancer; Malignant Biliary Obstruction; Pancreatitis
Abstract
Malignant biliary obstruction (MBO) is a clinically significant medical condition where the common bile duct (CBD) becomes blocked due to cancer. There are many causes of MBO including cancer of the pancreas, bile duct, and liver. Treatment involves performing an endoscopic retrograde cholangiopancreatography (ERCP) with insertion of a plastic or metal stent in the CBD to relieve the obstruction. Biliary stenting can potentially improve symptom-free survival and be beneficial in certain subgroup of patients. However, further research is needed to understand which patient population benefit from ERCP intervention considering its adverse events. The proposed project will include both a retrospective and prospective analysis of patients diagnosed with MBO undergoing biliary stenting. In the retrospective portion, we will assess various clinical outcomes including technical and procedural success, patient mortality, unplanned hospital visits, and procedural adverse events. In the prospective cohort of patients, we will assess the same clinical outcomes along with various patient reported outcomes and patient-centered outcomes. This includes quality of life measures, time to chemotherapy, healthcare contact and hospital free days. This project will be conducted at the Peter Lougheed Center by utilizing a well-maintained registry of patients undergoing ERCP procedures in Calgary since 2018. Results from this project will aim to provide real-world data on which subset of patients benefit from ERCP for the treatment of MBO. Establishing an evidence-based approach in this patient population will help improve clinical outcomes, reduce iatrogenic complications, and potentially lead to improvement in quality of life.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Malik, Getanshu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~